Champions Oncology, Inc. (CSBR) — 分析师展望 / 分析师共识目标价为. 基于 7 位分析师评级, 共识为 看涨 — 5 买入, 2 持有.
分析师共识目标价为 $12.00, 上涨空间为 94.2% 相对于当前价格 $6.18.
分析师预估 每股收益(EPS)为 $-0.63 和 营收为 $0.05B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.54 vs 预期 $-0.63 (超预期 +14.3%). 2025: 实际 $0.34 vs 预期 $0.30 (超预期 +13.3%). 分析师准确度: 86%.
CSBR 股票 — 12个月价格预测
$12.00
▲ +94.17% 上涨空间
平均目标价
Based on 7 Wall Street analysts offering 12-month price targets for Champions Oncology, Inc., the price target is $12.00.
平均目标价相对最新价格 $6.18 变动 +94.17%。
CSBR 分析师评级
Buy
基于过去3个月内 7 位分析师对 Champions Oncology, Inc. 的评级
EPS 预测 — CSBR
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.54
vs Est –$0.63
▲ 16.7% off
2025
Actual $0.34
vs Est $0.30
▲ 11.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
营收预测 — CSBR
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.050B
vs Est $0.049B
▲ 2.7% off
2025
Actual $0.057B
vs Est $0.057B
▲ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
